Dyax Corporation

Dyax Corp. (NASDAQ:DYAX) and FivePrime Therapeutics, Inc. enter into research agreement for Discovery of Therapeutic Antibodies 

CAMBRIDGE, Mass. & SOUTH SAN FRANCISCO--(BUSINESS WIRE)--Dyax Corp. (NASDAQ:DYAX) and Five Prime Therapeutics, Inc. (FivePrime) announced today that they have entered into an antibody funded research agreement for the discovery of therapeutic antibodies.